ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
116.78
+0.21 (0.18%)
At close: May 22, 2026, 4:00 PM EDT
117.00
+0.22 (0.19%)
After-hours: May 22, 2026, 7:15 PM EDT
ICLR Revenue
ICON Public Limited Company had revenue of $2.04B in the quarter ending September 30, 2025, with 0.63% growth. This brings the company's revenue in the last twelve months to $8.10B, down -2.46% year-over-year. In the year 2024, ICON Public Limited Company had annual revenue of $8.28B with 1.99% growth.
Revenue (ttm)
$8.10B
Revenue Growth
-2.46%
P/S Ratio
1.10
Revenue / Employee
$193,380
Employees
41,900
Market Cap
8.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.28B | 161.50M | 1.99% |
| Dec 31, 2023 | 8.12B | 378.79M | 4.89% |
| Dec 31, 2022 | 7.74B | 2.26B | 41.24% |
| Dec 31, 2021 | 5.48B | 2.68B | 95.93% |
| Dec 31, 2020 | 2.80B | -8.55M | -0.30% |
| Dec 31, 2019 | 2.81B | 210.06M | 8.09% |
| Dec 31, 2018 | 2.60B | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
| May 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 14.14B |
| Quest Diagnostics | 11.28B |
| Charles River Laboratories International | 4.03B |
| Revvity | 2.90B |
| Medpace Holdings | 2.68B |
| RadNet | 2.14B |
| Qiagen | 2.10B |
| Sotera Health Company | 1.19B |
ICLR News
- 4 days ago - ICON plc options imply 9.7% move in share price post-earnings - TheFly
- 7 days ago - Icon price target lowered to $120 from $175 at JPMorgan - TheFly
- 7 days ago - Icon resumed with a Sector Perform at RBC Capital - TheFly
- 11 days ago - Icon announces new Clinical Research Unit in San Antonio, Texas - TheFly
- 12 days ago - ICON expands US early phase research capabilities with new clinic and outpatient centres - Business Wire
- 20 days ago - HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem - GlobeNewsWire
- 21 days ago - Icon price target raised to $125 from $105 at Leerink - TheFly
- 25 days ago - Icon says Audit Committee completes investigation into accounting practices - TheFly